Correlation Between Larimar Therapeutics and Rain Therapeutics
Can any of the company-specific risk be diversified away by investing in both Larimar Therapeutics and Rain Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Larimar Therapeutics and Rain Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Larimar Therapeutics and Rain Therapeutics, you can compare the effects of market volatilities on Larimar Therapeutics and Rain Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Larimar Therapeutics with a short position of Rain Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Larimar Therapeutics and Rain Therapeutics.
Diversification Opportunities for Larimar Therapeutics and Rain Therapeutics
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Larimar and Rain is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Larimar Therapeutics and Rain Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rain Therapeutics and Larimar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Larimar Therapeutics are associated (or correlated) with Rain Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rain Therapeutics has no effect on the direction of Larimar Therapeutics i.e., Larimar Therapeutics and Rain Therapeutics go up and down completely randomly.
Pair Corralation between Larimar Therapeutics and Rain Therapeutics
Given the investment horizon of 90 days Larimar Therapeutics is expected to generate 0.61 times more return on investment than Rain Therapeutics. However, Larimar Therapeutics is 1.63 times less risky than Rain Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Rain Therapeutics is currently generating about -0.01 per unit of risk. If you would invest 398.00 in Larimar Therapeutics on September 16, 2024 and sell it today you would earn a total of 219.00 from holding Larimar Therapeutics or generate 55.03% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 29.03% |
Values | Daily Returns |
Larimar Therapeutics vs. Rain Therapeutics
Performance |
Timeline |
Larimar Therapeutics |
Rain Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Larimar Therapeutics and Rain Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Larimar Therapeutics and Rain Therapeutics
The main advantage of trading using opposite Larimar Therapeutics and Rain Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Larimar Therapeutics position performs unexpectedly, Rain Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rain Therapeutics will offset losses from the drop in Rain Therapeutics' long position.Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
Rain Therapeutics vs. Ocean Biomedical | Rain Therapeutics vs. Enveric Biosciences | Rain Therapeutics vs. Elevation Oncology | Rain Therapeutics vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |